Patritumab (U3-1287) | Technology Transfer

Skip to main content

Bookmarks
Register
Login

Partnerships
Partnerships

These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

Overview
Opportunities
Featured Technologies
Collaboration / CRADAs
Licensing Process
Forms / Model Agreements
Startups

Non-Profits
License Materials
Licensing FAQs
Business Opportunities
Product Showcase
Product Pipeline
Federal Register Notices

The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.
Royalties
Royalties

Information for inventors and licensees on the administration of royalties.

Information for NIH Inventors
Information for Licensees
License Notices / Reports

Royalty Coordinators
Payment Center

Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.
Reports
Reports

These links provide access to reports tracking the success of NIH licensed products.

Annual Reports
Tech Transfer Statistics
Tech Transfer Metrics
Commercial Outcomes
HHS License-Based Vaccines & Therapeutics
Public Health & Economic Impact Study

Stories of Discovery
Chen Lecture Videos
Active NIH Licenses and U.S. Patents
Media Room
Tech Transfer Newsletters
NIH Patents and Patent Applications

The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.
Resources
Resources

These links provide resources to those interested in the technology transfer activities at NIH.

Forms and Model Agreements
License Notices / Reports
Video Library
Inventor Resources

Presentations & Articles
FAQs
RSS Feeds
Inventor Showcase

Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.
Policy & Regulations
Policies & Regulations

These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

Freedom of Information Act (FOIA)
PHS Technology Transfer Policy

Policies & Reports
Useful Links

If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.
About
About Us

These links provide information about the Office of Technology Transfer.

Contact Us
Organization Chart
Staff Directory
Management
FAQs

HHS Tech Transfer Offices & Contacts
Careers in Tech Transfer
Location & Directions
Feedback

The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

Home
Introducing Product Pipeline
Patritumab (U3-1287)

Patritumab (U3-1287)

Broad Categorization

Cancer

Indication

Solid tumors

Licensee

U3 Pharma/Daiichi Sankyo

Phase

Phase II

Product Type

Patritumab (U3-1287)

Return to Top

About
Privacy Notice
Accessibility
Web Policies & Notices
Open Data

For NIH Staff Only
HHS
NIH
HHS Vulnerability Disclosure

Connect
Twitter
LinkedIn

Contact
Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health